216,39 €
Next Generation Antidepressants
Next Generation Antidepressants
  • Išparduota
Next Generation Antidepressants
Next Generation Antidepressants
El. knyga:
216,39 €
The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and foster…
  • Leidėjas:
  • Metai: 2010
  • ISBN: 9781139832571
  • ISBN-10: 1139832573
  • ISBN-13: 9781139832571
  • Formatas: ACSM ?
  • Kalba: Anglų

Next Generation Antidepressants (el. knyga) (skaityta knyga) | knygos.lt

Atsiliepimai

(2.50 Goodreads įvertinimas)

Formatai:

216,39 € El. knyga

Aprašymas

The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.

216,39 €
Prisijunkite ir už šią prekę
gausite
2,16 Knygų Eurų! ?

Elektroninė knyga:
Atsiuntimas po užsakymo akimirksniu! Skirta skaitymui tik kompiuteryje, planšetėje ar kitame elektroniniame įrenginyje.

Kaip skaityti el. knygas ACSM formatu?

Mažiausia kaina per 30 dienų: 216,39 €

Mažiausia kaina užfiksuota: Kaina nesikeitė

  • Leidėjas:
  • Metai: 2010
  • ISBN: 9781139832571
  • ISBN-10: 1139832573
  • ISBN-13: 9781139832571
  • Formatas: ACSM ?
  • Kalba: Anglų

The World Health Organization defines depression as a primary contributor to the global burden of disease and predicts it will become the second leading cause of death by 2020. The need to develop effective therapies has never been so pressing. Current antidepressant drugs have several limitations. This book looks at the future of mood-disorder research, covering the identification of new therapeutic targets, establishing new preclinical models, new medicinal chemistry opportunities, and fostering greater understanding of genetic influences. These strategies are likely to help build a better picture of the disease process, and lead to new opportunities for patient stratification and treatment. The ultimate goal for this strand of research is to develop more personalized and effective treatments for this chronic and debilitating condition. This is essential reading for all those involved in psychopharmacologic drug development, and mental health clinicians seeking a preview of discoveries soon to influence their practice.

Atsiliepimai

  • Atsiliepimų nėra
0 pirkėjai įvertino šią prekę.
5
0%
4
0%
3
0%
2
0%
1
0%
(rodomas nebus)
× Akcija + knyga už 1ct